Respiratory drugs Flashcards

1
Q

SABA examples

A

salbutamol, terbutaline, albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SABA main indications

A

first line treatment for mild intermittent asthma, COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mechanism of action of SABA

A

agonists of beta 2 adrenoceptors. causes bronchodilation and decreases mucous secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

contraindications of SABA

A

use in caution with patients with arrhythmias, CVD, diabetes, hypertension, hyperthyroidism, hypokalaemia, and susceptibility to QT interval prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adverse effects of SABA

A

tremor most common can also affect heart rhythm , oral thrush

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LABA main indications

A

nocturnal asthma, COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LABA mechanism of action

A

agonists of beta2 adrenoceptor, always administered with an ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Contraindications of LABA

A

use with caution in patients with arrhythmias, CVD, hyperthyroidism, hypokalaemia, susceptibility to QT interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

adverse effects of LABA

A

beta 2 down regulation and tachyphylaxis with chronic use, may worsen asthma when used alone should always be given with ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inhaled corticosteroids main indication

A

second line in asthma, consider for COPD where patient is a frequent exacerbator (2+ hopsital admissions a year) AND is eosinophilic (less than 300 cells/microlitre)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mechanism of action of ICS

A

synthetic derivatives of cortisol, anti inflammatory effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adverse effects of ICS

A

dysphonia and oropharyngeal candidiasis, pneumonia in COPD due to local immune suppression and impaired mucociliary clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Leukotriene receptor anatagonists main indication

A

add on in uncontrolled asthma (oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

leukotriene receptor antagonist mechanism of action

A

prevent CysLTs from causing bronchoconstriction, mucus secretion, oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

adverse effects of leukotriene receptor antagonists

A

generally well tolerated, headache, GI upset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Xanthines main indication

A

add on in uncontrolled asthma (theophylline oral), used in acute severe asthma attack (Iv aminophylline)

17
Q

xanthines mechanism of action

A

inhibit mediator release of mast cells, increase mucus clearance, increase diaphragmatic contractility and reduce fatigue. prevent inactivation of cAMP and cGMP (they relax smooth muscle and are antiinflammatory)

18
Q

xanthines contraindications

A

drug interactions involving CYP450s

19
Q

adverse effects of xanthines

A

very narrow therapeutic index- adverse effects at supratherapeutic concentrations include dysrthmia, seizures and hypotension. at therapeutic conc can cause nausea, vomiting, headache

20
Q

omalizumab

A

very expensive specialist treatment. injection every 2 -4 weeks. for asthma. anti IgE

21
Q

mepolizumab/ benralizumab

A

very expensive specialist treatment. injection every 4-8 weeks. for asthma. targets cytokine that activates eosinophils. - IL5

22
Q

dupilumab

A

very expensive specialist treatment. injection every 2 weeks. for asthma. blocks cytokines responsible for eosinophilic inflammation, IgE, airway hyper reactivity and mucin production

23
Q

SAMA example

A

ipratropium

24
Q

mechanism of action of SAMA

A

non selective m3 receptor antagonist- stops bronchoconstriction caused by M receptor activation in response to ACh. also reduces mucous secretion

25
Q

main indication of SAMA

A

highly nebulised dose used in acute COPD

26
Q

mucolytics main indication

A

COPD, cystic fibrosis

27
Q

adverse effects of mucolytics

A

diarrhoea, nausea, GI disturbance

28
Q

LAMA main indication

A

palliative effect for long term management of COPD

29
Q

LAMA mechanism of action

A

pharmacological antagonist of bronchoconstriction caused by M3 receptor activation in response to ACh